Weightwatchers International Inc.

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: North America, United Kingdom, Continental Europe and Other. The North America segment consists of United States and Canada company-owned operations. The United Kingdom segment includes United Kingdom company-owned operations. The Continental Europe segment consists of Germany, Switzerland, France, Spain, Belgium, Netherlands, and Sweden company-owned operations. The others segment offers Australia, New Zealand company-owned operations, as well as revenues and costs from franchises in the United States. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Weight Watchers to Lead Clinical Weight Management with Strategic Acquisitions

Weight Watchers International is confident in its ability to return to a growth trajectory by providing science-based solutions for weight management. The company's strategic acquisitions, enhanced marketing approach, and product enhancements position it well for future success in the weight management industry.

Weight Watchers beats Q1 targets, eyes growth through digital

Weight Watchers International's Q1 2023 performance exceeded expectations with strong subscriber growth and revenue results.
The company's focus on digital expansion, data-informed culture, and strategic acquisitions positions it well for future growth.
Challenges include intensifying competition, sustaining growth amidst lower marketing spend, and successful integration of acquisitions.
Opportunities lie in enhancing member experience, expanding in the clinical space, and leveraging brand equity for efficient growth.

WeightWatchers reports subscriber growth despite revenue challenges and supply shortages

WeightWatchers International is navigating challenges in revenue due to clinical supply shortages but is focusing on core business growth and member engagement. The company's strategic focus on weight health leadership and synergies between its core and clinical businesses present opportunities for growth and innovation.

Weight Watchers reports strong Q3 performance, eyes growth opportunities

Weight Watchers International (WW) delivered a strong performance in Q3, with notable subscriber growth, revenue, and margin expansion. The company's strategic focus on innovation, partnerships, and cost efficiency underpins its resilience and market competitiveness.
While facing challenges such as supply constraints and uncertainties in future guidance, Weight Watchers remains committed to sustainable growth through subscriber-centric strategies and operational agility. Opportunities lie in expanding Clinical offerings, targeted programs, and industry engagement.
Overall, Weight Watchers' Q3 earnings call highlights its financial strength, strategic direction, and commitment to driving subscriber growth and engagement. The company's performance underscores its ability to adapt, innovate, and navigate challenges in the competitive landscape.

Weight Watchers focuses on health, sees growth in subscribers

Weight Watchers International Inc. is prioritizing growth in clinical subscribers and subscription revenue, focusing on enhancing digital products, and differentiating itself through science and brand equity. The company is confident in delivering year-over-year growth in various key metrics for 2024.

WeightWatchers International Inc. reports strong Q1 performance and strategic growth initiatives

WeightWatchers International Inc. delivered a strong performance in Q1 2024, showcasing growth in clinical business, record margins, and strategic initiatives to drive long-term growth. While facing challenges in marketing strategy shifts and restructuring costs, the company is well-positioned to capitalize on opportunities in subscriber ARPU stabilization, B2B partnerships, and product enhancements.

WeightWatchers anticipates growth amidst challenges, emphasizes cost-saving measures

WeightWatchers International faces short-term challenges but remains optimistic about its financial performance for the year. The company is implementing cost-saving measures, focusing on strategic growth initiatives, and emphasizing the importance of expanding access and care options.

WeightWatchers reports Q3 revenue decline but focuses on growth

WeightWatchers International is navigating challenges while leveraging strengths to drive growth and operational efficiency.
The company's focus on innovation, brand revitalization, and cost savings aligns with long-term growth objectives.
Despite market dynamics, WeightWatchers remains optimistic about future demand and committed to strategic initiatives for turnaround.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Shares of WW International Inc. WW, -1.20% , which was formerly known as Weight Watchers, soared 25.2% toward a five-week high in premarket trading Tuesday, after the weight management and wellness company said it completed its acquisition of Weekend Health Inc., the telehealth company doing business as Sequence. The stock had rocketed 79.1% to a seven-month high of $6.93 on March 7 after the $132 million deal was announced, as the acquisition would provide WW a telehealth provider that prescribes weight-management and diabetes drugs.

Weight Watchers parent's stock soars after deal to buy weight-management drugs prescriber Sequence closes

NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced it has completed its acquisition of Weekend Health, Inc., d/b/a Sequence, a subscription telehealth platform offering access to healthcare providers specializing in chronic weight management. Sequence seamlessly integrates the patient and clinician experience for medication management and related clinical care while providing high-touch support in navigating the insurance approval process.

WW International, Inc. Completes Acquisition of Sequence

Agora

VirnetX

The stock market is down today because recession fears are returning to

3 Hot Penny Stocks To Watch With The Stock Market Down Today

Eli Lilly

Novo Nordisk

Novo Nordisk's business has been red-hot, thanks to soaring obesity-related revenue. Eli Lilly has its own promising weight-loss treatment which could be a game changer.

3 Stocks That Could Benefit From the Ozempic Craze

CVS Health

Teladoc

Healthcare tends to be a great place to hide during periods of uncertainty, and considering the best telehealth stocks to buy is one way to do more than just hide. There are several big trends emerging in healthcare right now, and most point to growth in online, at-home medical attention.

3 Top Stock Picks to Profit From the Telehealth Boom

WW International Inc. WW, +0.71% , the parent company of Weight Watchers, said late Thursday its chairman would not stand for re-election, and is stepping down. Raymond Debbane, the current chair, will step down the day before the company's May 9 annual meeting, WW said, with the board appointing Thilo Semmelbauer as chairman-elect.

Weight Watchers chairman to step down in May

NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced several upcoming changes to its Board of Directors (the “Board”) in connection with the Company's annual meeting of shareholders to be held on May 9, 2023 (the “2023 Annual Meeting”).

WW International, Inc. Announces Upcoming Changes to Board of Directors

WW International announced that it would acquire digital health company Sequence for a net consideration of about $106 million, as it looks to enter the increasingly popular obesity drug market.

WW International Stock Is A Buy Following Sequence Deal

WW International Inc (NASDAQ:WW), formerly known as Weight Watchers International, received plenty of attention yesterday after announcing the acquisition of telehealth provider Sequence.

Weight Watchers Stock Pulls Back After Buyout Boom

Tesla

Markets were modestly lower on Wednesday afternoon. Tesla dropped as its Model Y SUVs became the subject of a federal investigation.

Tesla Falls, but Wall Street's Really Pounding This Beaten-Down Stock

WW announced a major acquisition that removes a potential existential risk to the Company that investors fretted about. The new CEO has been systematic in utilizing a data-informed approach to member acquisition, increased marketing efficiency, and new product features to enhance the member experience.

WW International - Acquisition Removes Major Risk, Return To Growth Ahead

Walgreens

Fed Chair Jerome Powell said the central bank could raise rates more than expected if economic data remain strong.

Stock Market Today: Blue Chip Stocks Lead Market Lower After Powell Speech

WeightWatchers has agreed to acquire telehealth obesity treatment company Sequence.

WeightWatchers stock surges 70% after company agrees to buy obesity treatment platform

Weight Watchers is buying a telehealth provider that prescribes sought-after weight-management and diabetes drugs in a deal that reinforces how a new class of therapies has revolutionized the way many Americans think about weight loss.

Why Weight Watchers is buying a company that prescribes popular weight-loss drugs like Ozempic

For months, the healthcare community has been focused on a new drug. The brand name of semaglutide, Ozempic, first gained notoriety as a method for treating Type 2 diabetes.

How Ozempic Just Sent Weight Watchers (WW) Stock Up 30%

WeightWatchers is getting into the booming prescription weight loss drug business.

WeightWatchers jumps into the prescription weight loss drug business

WW International Inc. WW, -8.94% , also known as Weight Watchers, said in its 2022 annual report filed Tuesday that it had 7,100 employees as of Dec. 31, to mark the fourth-straight year that the wellness and weight management company has cut jobs. Meanwhile, the stock shot up 19.4% toward a one-month high in premarket trading, after the company reported late Monday fourth-quarter results and said it was buying telehealth platform Sequence for $106 million.

Weight Watchers parent WW workforce drops again to less than half what it was pre-pandemic

Grindr Inc

Meta shares rise after new wave of layoffs, WeightWatchers' stock makes gains after results and acquisition; Grindr's stock falls after profit drop

Former WeightWatchers is entering clinical weight management. WW stock surged.

WW Stock Soars As Telehealth Deal Opens Up Hot Obesity Drug Market

WeightWatchers is acquiring subscription telehealth platform Weekend Health, which does business as Sequence. The planned acquisition will add Sequence's platform, which offers access to healthcare providers who specialize in chronic weight management, to WeightWatchers' other weight loss and weight management tools, WeightWatchers said in a Monday (March 6) press release.

WeightWatchers Acquiring Subscription Telehealth Platform Weekend Health

WeightWatchers is acquiring Sequence, a digital health platform for weight loss management, that reportedly prescribes weight loss drugs like Ozempic.

WeightWatchers is buying a company that lets you pay $99 a month to see a doctor on video and get a prescription to popular weight-loss drug Ozempic

WW International, Inc. (NASDAQ:WW ) Q4 2022 Results Conference Call March 6, 2023 5:00 PM ET Company Participants Corey Kinger - Investor Relations Sima Sistani - Chief Executive Officer Heather Stark - Interim Principal Financial Officer Conference Call Participants Alex Fuhrman - Craig-Hallum Capital Group Brian Nagel - Oppenheimer Linda Bolton-Weiser - D.A. Davidson Michael Lasser - UBS Jason English - Goldman Sachs Operator Good afternoon, and welcome to the WW International Fourth Quarter and Full Year 2022 Earnings Conference Call.

WW International, Inc. (WW) Q4 2022 Earnings Call Transcript

WW International (WW) delivered earnings and revenue surprises of 50% and 0.92%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

WW International (WW) Q4 Earnings Surpass Estimates

WW's stock jumped more than 13% in after-hours trading following news of the deal Monday.

WeightWatchers Buying Telehealth Service Known For Ozempic Weight Loss Prescriptions, Report Says

WW International Inc., the company that oversees the weight-loss program Weight Watchers, forecast first-quarter sales that were below expectations Monday, and said member signups were down so far this year amid a shift in marketing spending.

Weight Watcher' sales forecast comes up short, and subscribers are down. But it's reportedly buying its way into telehealth, with diabetes and obesity drugs

News for Weightwatchers International Inc. Stock (WW)